Attached files
| file | filename |
|---|---|
| 8-K - FORM 8-K - OPKO HEALTH, INC. | d741430d8k.htm |
| EX-99.2 - EX-99.2 - OPKO HEALTH, INC. | d741430dex992.htm |
| EX-99.1 - EX-99.1 - OPKO HEALTH, INC. | d741430dex991.htm |
 FineTech
JUNE 12, 2014
Exhibit 99.3
Welcome to FineTech Pharmaceutical |
 FineTech
JUNE 12, 2014
•
Manufactures high value, low volume specialty APIs and provides
organic synthesis capabilities for OPKO's drug development projects
•
Operates in a 35,000 sq. ft. sate of the art, FDA approved facility
with top of the line equipment
•
Employs a highly motivated, experienced and creative team of 40
employees, mostly with Ph.D. or M.Sc. degrees
•
Customers include leading generic pharmaceutical companies in the
USA, Canada, Europe, Israel and South America
•
Cost-efficient business with rapidly growing sales and very high
margins |
 FineTech
JUNE 12, 2014
What is the SECRET of this exceptionally high profitability?
QUESTION:
|
 FineTech
JUNE 12, 2014
•
Facility/Equipment
•
Science/Technology
•
Ability to Create Intellectual Property
•
Regulatory Affairs
•
Effective Management of a Creative Team
•
Commercial Acumen in choosing the right product at the right time
ANSWER:
PERFECT QUALITY MIX
|
 FineTech
JUNE 12, 2014
This PERFECT QUALITY MIX enables a customer to
be the first generic company to launch a specialty
product with complex chemistry or patent
challenges. In such cases companies are prepared
to pay substantial premiums and commit to long-
term agreements. |
 FineTech
JUNE 12, 2014
Cabergoline
Latanoprost
Nabilone
Travoprost
Bimatoprost
|
 FineTech
JUNE 12, 2014
SR-3306 – treatment of Parkinson disease
C-34 – anti-tumor and immune-stimulating activity Disaccharides –
treatment of asthma
Different derivatives of vitamin D and CYP -24
inhibitors
|
 FineTech
JUNE 12, 2014 |
 FineTech
JUNE 12, 2014 |
 FineTech
JUNE 12, 2014 |
 FineTech
JUNE 12, 2014 |